Literature DB >> 26648611

Data informs debate.

Elizabeth Roughead1.   

Abstract

Keywords:  drug evaluation; drug information; drug regulation

Year:  2015        PMID： 26648611      PMCID： PMC4653991          DOI： 10.18773/austprescr.2015.014

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  8 in total

1.  Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.

Authors:  Robert M Califf; Deborah A Zarin; Judith M Kramer; Rachel E Sherman; Laura H Aberle; Asba Tasneem
Journal:  JAMA       Date:  2012-05-02       Impact factor: 56.272

2.  New drugs: evidence relating to their therapeutic value after introduction to the market.

Authors:  Mariam Ujeyl; Claudia Schlegel; Siegbert Walter; Ursula Gundert-Remy
Journal:  Dtsch Arztebl Int       Date:  2012-02-17       Impact factor: 5.594

3.  Factors influencing non-approval of new drugs in Europe.

Authors:  Michelle Putzeist; Aukje K Mantel-Teeuwisse; Bo Aronsson; Malcolm Rowland; Christine C Gispen-de Wied; Spiros Vamvakas; Arno W Hoes; Hubert G M Leufkens; Hans-Georg Eichler
Journal:  Nat Rev Drug Discov       Date:  2012-12       Impact factor: 84.694

4.  Dabigatran, bleeding, and the regulators.

Authors:  Thomas J Moore; Michael R Cohen; Donald R Mattison
Journal:  BMJ       Date:  2014-07-23

Review 5.  Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors:  D Mukherjee; S E Nissen; E J Topol
Journal:  JAMA       Date:  2001 Aug 22-29       Impact factor: 56.272

6.  Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

Authors:  Steven E Nissen; Kathy Wolski; Eric J Topol
Journal:  JAMA       Date:  2005-10-20       Impact factor: 56.272

Review 7.  Reanalyses of randomized clinical trial data.

Authors:  Shanil Ebrahim; Zahra N Sohani; Luis Montoya; Arnav Agarwal; Kristian Thorlund; Edward J Mills; John P A Ioannidis
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

8.  Number of patients studied prior to approval of new medicines: a database analysis.

Authors:  Ruben G Duijnhoven; Sabine M J M Straus; June M Raine; Anthonius de Boer; Arno W Hoes; Marie L De Bruin
Journal:  PLoS Med       Date:  2013-03-19       Impact factor: 11.069
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.